OasisLMS

Clinical trial research advances have been pivotal to the ongoing optimization of advanced prostate cancer management throughout the past decade. Continued clinical trial research will be equally important in the decade ahead and beyond as urologists and oncologists continue to advance new and improved treatment strategies for advanced prostate cancer. This program provides a guide to the landmark trials, emerging evidence, and upcoming research shaping the treatment of advanced prostate cancer. Made possible by a generous endowment from Chesapeake Urology Associates, “Advanced Prostate Cancer Clinical Trial Research: A Decade of Progress and the Road Ahead” brings together some of urology’s leading independent practice clinical trial investigators for 60-minute, live webinar exploring clinical trial research updates in advanced prostate cancer.

Support provided by a Urology Care Foundation endowment fund made possible by Chesapeake Urology Associates.

• Advanced Practice Providers
• Clinical Fellows
• Clinical Research Teams
• Investigators
• Post-Doctoral and Research Fellows
• Researchers/Scientists
• Residents
• Urologists

After participating in this activity, participants will be able to:

1. Apply guidance from the Prostate Cancer Clinical Trials Working Group 4 in interpreting recent advanced prostate cancer clinical trial results.
2. Consider integration of new and emerging technologies and therapies into current advanced prostate cancer research and future clinical practice to ultimately improve patient outcomes.
3. Enhance current advanced prostate cancer clinical trial research efforts through integration of artificial intelligence and digital oncology approaches.
4. Address evidence gaps and unanswered questions into current and future clinical trial research efforts for advanced prostate cancer.

• Gordon Brown, DO
• Jose De La Cerda III, MD
• Jason Hafron, MD
• Suzanne Merrill, MD
• Gregory McMahon, DO
• Neal Shore, MD